Last reviewed · How we verify
NCT06620133: CAPACITY
Pain Education and Patient-led Goal Setting in Adults With Chronic Low Back Pain: a Randomised Controlled Trial
NA trial testing Pain education and patient-led goal setting in Chronic Low Back Pain (Non-specific, Uncomplicated) in 392 participants. Currently enrolling.
31 December 2028
Quick facts
| Lead sponsor | Neuroscience Research Australia |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 392 |
| Start date | 26 June 2025 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2029 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Pain education and patient-led goal setting
- Guideline-based written advice
Conditions studied
- Chronic Low Back Pain (Non-specific, Uncomplicated) — all drugs for Chronic Low Back Pain (Non-specific, Uncomplicated) →
Sponsor
Neuroscience Research Australia
Who can join
18 and older, any sex, with Chronic Low Back Pain (Non-specific, Uncomplicated). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to investigate the effectiveness of two treatments for adults with chronic low back pain. The main question this study seeks to answer is "In adults with chronic low back pain, what is the effectiveness of pain education and patient-led goal setting compared to guideline-based written advice on reducing pain intensity and disability?". A total of 392 participants will be randomised into two groups: 1) pain education and patient-led goal setting or 2) guideline-based written advice. Participants randomised to the pain education and patient-led goal setting group will receive 5 sessions of 45-60 min each over 8 weeks delivered online via telehealth. Participants randomised to written advice group will receive information developed for people with chronic low back pain. Outcomes will be assessed at baseline and week 8, 26 and 52.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06620133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Low Back Pain (Non-specific, Uncomplicated)
Currently open trials in the same condition.
- NCT07248813 — Telerehabilitation Program to Improve Function in People With Chronic Low Back Pain Compared With Conventional Care · NA · recruiting
Other Neuroscience Research Australia trials
Trials by the same sponsor.
- NCT07205991 — ADHERE Trial: Strategies to Improve Mobile App Adherence · NA · recruiting
- NCT06984354 — Digitally Delivered Treatments to Reduce Chronic Low Back Pain · NA · recruiting
- NCT06605248 — NOTUS Feasibility Study: Reducing Chronic Low Back Pain With Mobile App Intervention · NA · completed
- NCT06535646 — Digital Health Technology for People With Mitochondrial Disease · NA · recruiting
- NCT06504433 — The Natural History of Mitochondrial Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06620133 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neuroscience Research Australia
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06620133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing